Endocrinology or Diabetology Clinical Trials

The incidence of diabetes and obesity are increasing on a global scale and ProRelix Research is playing a significant role in supporting development of new therapies to treat these types of chronic metabolic disorders.
We have deep experience and expertize not only in recruiting specialized patient populations but also in retaining them for longer-term studies.
ProRelix’s Endocrinology and Diabetes experience include over many studies in different phases through Registry and with Medical Devices IDE and non-IDE stages. Specifically, we have completed studies in a wide range of conditions including but not limited to

  • Hyperparathyroidism
  • Type I Diabetes
  • Type II Diabetes
  • Obesity

Significantly we have also completed several studies including pediatric subjects in this therapy area. Through our endocrinology expertize, ProRelix becomes your trusted partner and adds immediate value to your project.

About Us

ProRelix Research is the best clinical research organization (CRO) with global service capability supporting Phase 1, 2, 3, & 4 clinical trials for Pharma, Biotech, Biopharma, Medical device, Nutraceutical & Herbal companies in US, India, Australia, & Europe.

Subscribe Blogs & Newsletter
Loading
Inquire Now
close slider





      Register Now

      All the fields are mandatory